The present invention relates generally to the retention of particles prior to the needleless injection of those particles in a gas stream. More specifically, the present invention relates to particle cassettes having a pair of membranes which retain the particles in a chamber therebetween.
Needleless syringe devices are known from WO 94/24263. In this document, a needleless syringe is disclosed which entrains particles in a gas stream accelerated through a nozzle so that the particles may be injected into a target, such as human skin or other cells. For many applications, there is a need for the particles to be maintained in a sterile environment prior to actuation of the device. WO 94/24263 discloses for this purpose a particle cassette comprising a central annular ring having rupturable diaphragms sealed to each face so as to form a self contained sealed unit containing the particles to be injected. Upon actuation of the device, the diaphragms rupture allowing the particles initially contained between the diaphragms to be entrained in the gas flow and then delivered into the target.
a to 1d of the accompanying schematic drawings show steps in the manufacture of the particle cassette disclosed WO 94/24263. A substantially annular ring (10) is shown in axi-symmetric cross-section in
An exemplary needleless syringe is shown in
WO 94/24263 discloses that the diaphragm should preferably be heat sealed to the faces of the annular ring. Heat sealing has been found to be a particularly easy and repeatable method of sealing the diaphragms to the ring of the cassette body.
It has been found that the above-mentioned configuration has a disadvantage associated with its manufacture, which may become especially deleterious when heat-sensitive particles (e.g. powdered drugs) are to be carried by the cassette. After the particles have been supplied to the chamber (11) formed by the annular ring (10) and the bottom membrane (12), the heat sealing of the top membrane (14) onto the ring (10) can sometimes result in a degradation of the particles. This degradation may take the form of melting, causing particle deformation, particle agglomeration and other undesirable physical and chemical changes in the product. Further, the melt may affect the therapeutic effect of the particles.
Accordingly, the present invention seeks to alleviate this problem by providing a particle cassette, a kit of parts and a method for the manufacture therefor in which the possibility of the particles melting during manufacture is much reduced.
In accordance with the first aspect of the present invention, there is provided a kit of parts for use in the manufacture of a particle cassette for a needleless syringe device, said kit comprising:
Thus, since the membranes are sealed to first and second cassette parts (possibly by heat sealing) before the particles are supplied to either of the cassette parts, there is a much reduced possibility of the membrane heat sealing process influencing the particle condition or composition. Further, the invention provides a quick and easy method of manufacturing a particle cassette and has these advantages over processes which do not involve heat sealing.
Preferably, the first and second cassette parts are annular such that the second part is attachable concentrically around or inside the first cassette part. This allows the first cassette part to extend substantially along the whole width of the particle cassette making it easier to fill the first part with particles prior to attaching the second part.
To attach the first and second parts together, a variety of mechanisms may be used, including interference fits, friction fits, screw fits, detents and recesses, close tolerances, gluing etc. A snap fit may be provided for by arranging corresponding features on each of the first and second parts (for example a detent and a recess).
In order to ensure a consistent width of particle cassette, it is preferable to provide a seating face on each of the first and second parts, such a seating face providing a minimum possible width of particle cassette when assembled.
A tapered face on each of the first and second parts allows the parts to be brought together easily during assembly.
A third cassette part may be used to attach the first and second parts together. In a preferred embodiment, the third cassette part is inserted in an annular apace between the first and second cassette parts, to provide a secure attachment (or “locling”). The third part preferably has a third membrane to ensure sterility and may be provided with one or more protrusions to ensure an interference fit with the second cassette part.
In a second aspect of the invention, there is provided a particle cassette for a needleless syringe comprising an assembled kit according to the first aspect and particles provided in the chamber between the first and second membranes.
According to a third aspect of the present invention, there is provided a needleless syringe including the particle cassette of the second aspect of the invention.
According to a fourth aspect of the invention, there is provided a method of assembling a particle cassette for a needleless syringe device, said method comprising:
The sealing of the membranes to the cassette parts independently from the steps of supplying particles to one of the cassette parts and attaching the cassette parts together ensures that the method used for sealing the membranes to the cassette parts does not unduly influence the quality of the particles in the cassette.
Preferably, attaching step (d) does not involve the application of any heat at all and it is preferably carried out at the same temperature as supplying step (c) to ensure that the particles are not affected by the step of attaching the first and second cassette parts together.
It is not essential that supplying step (c) is carried out after sealing step (b) since the second membrane may be sealed to the second cassette part after the particles have been supplied to the first cassette part.
Embodiments of the present invention will now be described, by way of example only, with reference to the accompanying schematic drawings, in which:
a to 1d are cross-sectional views showing stages in the manufacture of a particle cassette according to the prior art;
a and 2b are cross-sectional views showing stages in the manufacture of a particle cassette according to a first embodiment of the invention;
In the drawings the components are not drawn to scale. The drawings are schematic for reasons of clarity. In reality the thickness of the rupturable diaphragms may be much less than that shown and/or the volume of particles may be so small as barely to be visible to the naked eye.
The present invention avoids the possibility of the heat sealing of the membranes affecting the particle quality by ensuring that the particles are confined within the chamber of the cassette by a step other than one involving heat sealing of one of the membranes. Thus, generally speaking, each of the embodiments of the present invention comprises a first cassette part (20) having a first membrane (22) sealed to a face and a second cassette part (21) having a second membrane (23) sealed to a face. Particles (24) are dispensed into the first cassette part and the second cassette part is then attached. The attachment step should not involve the application of an amount of heat such as is likely to damage the particles. However, heat sealing can be used in the attachment step if the heat is used such that the particles are not likely to be damaged.
a and 2b show an axi-symmetric cross-section of the particle cassette according to the first embodiment of the present invention.
In the first embodiment, the first cassette part (20) comprises an annular ring having a first face (the upper face in
In order to manufacture the particle cassette, particles (24) are dispensed to the first cassette part (20) and the first (20) and second (21) cassette parts are attached together so as to create a closed chamber for the confinement of the particles (24) between the first (22) and second (23) membranes. The assembled particle cassette is shown in
In use, the particle cassette is located in a needleless syringe device which may have the general construction, and method of operation, described in WO 94/24263 or WO 01/05455, the contents of which are hereby incorporated by way of reference. When located in the syringe device the device construction is advantageously such as to prevent the first cassette part (20) coming away from the second cassette part (21). However, in order to mitigate against further such detachment, the second cassette part (21) may be adhered to the first cassette part (20), for example by gluing or by taping around the external circumference of the particle cassette. This provides a sealed unit of particles which can be handled outside of the needleless syringe device with reduced possibility of particles escaping from between the two cassette halves.
A second embodiment of the invention is shown in
In the second embodiment, the first cassette part (20) is constituted by a substantially annular member which extends to a height X nearly equal to the height Y of the assembled particle cassette. This greatly facilitates the filling of the first cassette part (21) with particles (24) since a larger receptacle than is provided in the first embodiment can be used to receive particles (24). A further advantage is that the whole internal volume of the cassette can be used to hold particles. In contrast, the first embodiment can only be half filled with particles since the first cassette part (20) has a height equivalent only to approximately half the final height of the cassette.
The second cassette part (21) also has a substantially annular construction and is arranged to be attachable concentrically around the first cassette part (20). If necessary, adhesive can be used at the interface (25) to ensure that the first and second cassette parts do not detatch easily. More preferred, however, is that the cassette parts are attached by an interference fit, whereby the outer diameter of the engaging region of the first cassette part is slightly larger than the inner diameter of the engaging region of the second cassette part (21). In this way, the parts will naturally lock together due to the elastic strain established in each of the first and second cassette parts when the second part (21) is placed around the first part (20).
The second embodiment shown above has advantages over the first embodiment because it does not necessarily require an extra adhesive to be used (an interference fit is instead used) and because the first cassette part defines a larger receptacle area for receiving the particles (24). However, the second embodiment has the disadvantage that it may be difficult or fiddly to assemble, even if one or both of the engaging inner face of the second cassette part and the engaging outer face of the first cassette part is provided with a lead in taper to aid assembly. To overcome this problem, a cassette according to the third embodiment of the invention is provided. Such a cassette is shown in
In the third embodiment of the present invention, the outer engaging face of the first cassette part (20) and the inner engaging face of the second cassette part (21) (the interface of which is denoted as (26) in
The third embodiment of the invention thus has the advantage that it is easier to assemble the kit of parts than the second embodiment of the invention. However, it has the potential disadvantage that the width of the cassette (ie the vertical dimension in
To overcome this problem, a particle cassette as shown in the fourth embodiment of the invention is provided.
In this embodiment, a seating face (27) is provided to each of the first (20) and second (21) cassette parts. As is shown in
While an interference fit is suitable for a lot of purposes, it is often preferable that no elastic strains are built up in the first and second cassette parts, especially if they are to be re-used a lot of times. The fifth embodiment of the invention addresses this problem.
The main difference is the provision on each of the first (20) and second (21) cassette parts of corresponding features (28, 29) which provide for a snap fit when the first and second cassette parts are brought together. In particular, the first cassette part (20) comprises a detent (28) located on one of external tapered surfaces (26). Correspondingly, the second cassette part (21) comprises a recess (29) on its respective tapered surface (26). Thus, when the first and second cassette parts are brought together, the detent (28) locates in the recess (29) to lock the two pieces together. During this attaching step, both the first and second cassette parts undergo a momentary elastic strain as the detent (28) engages in the recess (29) but, once assembled, the cassette part can be arranged so that there is little residual strain present. This means that there is no requirement to rely on an interference fit alone to maintain the first and second cassette parts in attachment. The provision of corresponding features also makes it more difficult for the first and second parts to be accidentally detached, providing a stronger lock between the first and second cassette parts and thus a more secure sealed environment for the particles. This is particularly useful when the cassette is to be subject to vibrations, such as those experienced during transportation. The fifth embodiment shown in
The fifth embodiment has a further advantage in that it provides an assembly that is tamper evident. Once assembled, it is very difficult to prise the cassette parts apart due to the taper lock and detent arrangement. Thus, the assembly could only be opened by destroying one of the membranes or using a very sharp tool to lever apart the parts, which in practice causes obvious deformation of the cassette parts.
Referring back to
The third cassette part (50), in common with the first and second cassette parts, has generally cylindrical inner and outer walls forming an annular-shaped member. One or more protrusions (51) may be formed on the outer walls and these are intended to provide an interference fit against the inner wall (34) of the second cassette part (30), when the particle cassette is assembled. The lower end of the third cassette part (50) has a number of formations (52) around the circumference. The formations (52) are stepped and are designed such that the top part (53) of the formations (52) abuts the top surface of the first cassette part (40) when assembled, as shown in
The particle cassette according to the sixth embodiment of the invention takes the form shown in
To assemble the particle cassette of the sixth embodiment, a first membrane (62) is heat sealed or bonded to the upper edge of the first cassette part (40). Similarly, the second membranes (63) is heat sealed or bonded to the seating face (32) of the second cassette part (30). The third membrane (61) is heat sealed or bonded to the upper face of the third cassette part (50). The first membrane and first cassette part thus define a receptacle in which the particles may be contained. The openings (43) are very small such that it is very difficult for the particles to pass out of the chamber once inside. Once the particles have been supplied to the chamber of the first cassette part (40), the first cassette part (40) is brought together with the second cassette part (30) with the leading edge of the first cassette part engaging the shoulders (31) of the second cassette part. The first cassette part (40) is pushed home until the seating face (41) of the first cassette part abuts the seating face (32) of the second cassette part (with the second membrane (63) between the two seating faces). In this configuration, the particles are trapped between the first and second membranes. The third cassette part (50) having the third membrane (61) thereon is then pushed in so that the formations (52) slide into the annular gap created between the first and second cassette parts. Interference and/or friction ensure that this movement firmly secures the first and second parts together and effectively “locks” the cassette. It will be appreciated that it is quite difficult to remove the third cassette part once it is installed, especially if the top face (55) of the third cassette part is dimensioned so as to be flush with the top face of the second cassette part when assembled (this is not shown in
The membrane (61) ensures that the particles inside the cassette may not come into contact with any external particles or gases and thus the membrane (61) ensures the sterility of the cassette.
In use, the cassette is inserted into a needleless syringe and gas pressure is supplied to the third membrane (61). The membrane (61) bursts quite easily and gas enters the internal space defined by the third cassette part. Gas is able to flow through the vents (54) and into the annular space (67) between the first cassette part and the second cassette part. From there, gas may pass through the transfer ducts and out through the openings (43) into the particle containment chamber. The jets of gas so formed cause the particles to be fluidized and mixed. Following that, the upstream membrane (62) bursts and the particles are entrained in the bulk of the gas flow followed by the bursting of the downstream membrane (63) shortly thereafter. In this way, the particle cassette of the sixth embodiment provides for pre-mixing and fluidizing of the particles whilst still overcoming the problem that heat sealing of membranes can damage particles when a single piece cassette is used.
The concepts described in relation to the first to fifth embodiments may also be applied to the sixth embodiment in the same way. For example, a snap fit may be provided for if detents and corresponding recesses are provided on either the first and second, first and third or second and third cassette parts respectively.
Heat sealing or adhesive is not necessary in the sixth embodiment and the first and second membranes may be sealed against the first and second cassette parts respectively due to the tight fit between the various cassette parts. For example, the first membrane (62) may be sealed by virtue of being trapped between the first and third cassette parts. Similarly, the second membrane (63) may be trapped between the first and second cassette parts, with no special heat sealing or adhesive step being required.
As can be seen from
To overcome this problem, a particle cassette as shown in the seventh and eighth embodiments of the invention is provided. The particle cassette itself has a built in expansion chamber (120) meaning that the syringe has less components overall. This results in a decrease in manufacturing time and complexity.
The seventh embodiment of the invention is shown in
It will also be apparent from
It can be seen that the particle cassette of the seventh embodiment retains the advantages of the previous embodiments in that the particles can be located in chamber (77) and the two cassette parts pressed together to confine the particles in a chamber, without the need to subject the particles to the heating that often accompanies sealing the membranes to the cassette parts. Furthermore, the seventh embodiment integrates part of the needleless syringe, viz, the expansion chamber (120), with the particle cassette, thereby reducing the number of components and the manufacturing time and expense.
An eighth embodiment of the invention is shown in
It will be apparent from both
The screw thread is preferably relatively coarse such that the first and second cassette parts can be connected together with relatively few turns. Preferably, less than one turn of relative movement is necessary, more preferably 180° or less of relative rotation. In the most preferred embodiment, a range of movement between 45° and 120°, preferably 90° is sufficient to attach the first and second cassette parts together.
Of course, the various means for attaching the cassette parts shown in the first to seventh embodiments may be combined with the features of the eighth embodiment, for example, seating faces, tapers and detents which provide a “snap-fit” can all be used in combination with the screw thread attachment. Furthermore, a third cassette part may be used in the seventh and eighth embodiments to lock the first and second cassette parts together.
It will be noted from
The screw thread design of the eighth embodiment has been found to give a more reproducible face seal between the mating surfaces of the first and second cassette part. This helps to prevents egress of payload from the chamber (87) inside the assembled cassette, and gives a more consistent barrier to potential biological contamination. Furthermore, the integration of the expansion chamber (120) with the particle cassette makes the overall dimensions of the cassette larger than in the prior art which facilitates handling and manipulation during manufacture of the needleless syringe comprising the cassette.
It is envisaged that other embodiments falling within the scope of the present claims can be provided by using combinations of the various attaching methods disclosed in the first to eighth embodiments herein. The type of attaching means to be used depends on the circumstances. For example, there are occasions when a “snap-fit” action is not suitable because the snapping provides a vibrational jolt to the cassette assembly which may damage particularly fragile particles. In such cases, an interference fit or screw fit is preferred.
For each of the embodiments, the materials used to manufacture the cassette parts and the membranes may be conventional, for example, the membranes may be Mylar as disclosed in WO 94/24263 and the first and second cassette parts are preferably manufactured from a plastics material, using injection moulding for example. Both the membranes and cassette parts may be made from polycarbonate such as Evaxone 260 (EVA) polymer. If heat sealing is used, a temperature of 110° C. and pressure of 760 kPa (110 psi) for 1.5 seconds has been found to be acceptable.
The cassette is suitable for any type of particle that one intends to deliver, including powdered drugs (therapeutics, medicaments, vaccines, anaesthetics, analgesics, and the like), diagnostic particles (whether inert or comprising an active ingredient), and carrier particles coated with peptides, proteins or genetic material.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/GB02/03395 | 7/25/2002 | WO | 00 | 5/5/2004 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO03/011379 | 2/13/2003 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1300654 | Rose | Apr 1919 | A |
1434460 | Tibbatts | Nov 1922 | A |
1774258 | English | Aug 1930 | A |
1861047 | Colton | May 1932 | A |
2147158 | Goldenthal | Feb 1939 | A |
2151418 | Bolte | Mar 1939 | A |
2307986 | Bolte et al. | Jan 1943 | A |
2314527 | Taylor | Mar 1943 | A |
2470298 | Fields | May 1949 | A |
2478715 | Schmitt | Aug 1949 | A |
2594093 | Thompson | Apr 1952 | A |
3216562 | Lockood | Nov 1965 | A |
3324902 | Lense | Jun 1967 | A |
3508677 | Laibson et. al. | Apr 1970 | A |
3659600 | Merrill | May 1972 | A |
3664495 | Graham et al. | May 1972 | A |
3674028 | Ogle | Jul 1972 | A |
3735761 | Hurschman et al. | May 1973 | A |
3736933 | Szabo | Jun 1973 | A |
3782380 | Van Der Gaast | Jan 1974 | A |
3788315 | Laurens | Jan 1974 | A |
3797490 | Hurschman et al. | Mar 1974 | A |
3797491 | Hurschman | Mar 1974 | A |
3810469 | Hurschman | May 1974 | A |
3967761 | Melton, Jr. et al. | Jul 1976 | A |
4031892 | Hurschman | Jun 1977 | A |
4081077 | Franck | Mar 1978 | A |
4180173 | Diaz | Dec 1979 | A |
4226236 | Genese | Oct 1980 | A |
4360969 | Collier | Nov 1982 | A |
4362242 | Cheetham | Dec 1982 | A |
4416370 | Beall | Nov 1983 | A |
4474303 | Maccise | Oct 1984 | A |
4515586 | Mendenhall et al. | May 1985 | A |
4517815 | Basso | May 1985 | A |
4581875 | MacLaughlin et al. | Apr 1986 | A |
4596556 | Morrow et al. | Jun 1986 | A |
4627432 | Newell et al. | Dec 1986 | A |
4703863 | Kohus | Nov 1987 | A |
4738817 | Wittwer et al. | Apr 1988 | A |
4774085 | Fidler | Sep 1988 | A |
4778054 | Newell et al. | Oct 1988 | A |
4778068 | Kohus | Oct 1988 | A |
4811731 | Newell et al. | Mar 1989 | A |
4852757 | Gold | Aug 1989 | A |
4858759 | Mauthe et al. | Aug 1989 | A |
4863017 | Vlock | Sep 1989 | A |
4893721 | Bodenmann et al. | Jan 1990 | A |
4910866 | Allen | Mar 1990 | A |
4939827 | Iizuka | Jul 1990 | A |
4945050 | Sanford et al. | Jul 1990 | A |
4966581 | Landau | Oct 1990 | A |
4991377 | Marchesini | Feb 1991 | A |
5036006 | Sanford et al. | Jul 1991 | A |
5042472 | Bunin | Aug 1991 | A |
5046618 | Wood | Sep 1991 | A |
5053389 | Balschmidt et al. | Oct 1991 | A |
5062830 | Dunlap | Nov 1991 | A |
RE33801 | Green | Jan 1992 | E |
5100792 | Sanford et al. | Mar 1992 | A |
5102388 | Richmond | Apr 1992 | A |
5120657 | McCabe et al. | Jun 1992 | A |
5141496 | Dalto et al. | Aug 1992 | A |
5149655 | McCabe et al. | Sep 1992 | A |
5179022 | Sanford et al. | Jan 1993 | A |
5188615 | Haber et al. | Feb 1993 | A |
5204253 | Sanford et al. | Apr 1993 | A |
5207217 | Cocozza et al. | May 1993 | A |
5228573 | Pavelle et al. | Jul 1993 | A |
5239991 | Chawla et al. | Aug 1993 | A |
5256142 | Colavecchio | Oct 1993 | A |
5349947 | Newhouse et al. | Sep 1994 | A |
5360410 | Wacks | Nov 1994 | A |
5371015 | Sanford et al. | Dec 1994 | A |
5394980 | Tsai | Mar 1995 | A |
5415162 | Casper et al. | May 1995 | A |
5422129 | Draddy | Jun 1995 | A |
5474195 | Pai | Dec 1995 | A |
5478744 | Sanford et al. | Dec 1995 | A |
5492112 | Mecikalski et al. | Feb 1996 | A |
5533505 | Källstrand et al. | Jul 1996 | A |
5560490 | Chawla | Oct 1996 | A |
5575281 | Mecikalski | Nov 1996 | A |
5584807 | McCabe | Dec 1996 | A |
5630796 | Bellhouse et al. | May 1997 | A |
5658892 | Flotte et al. | Aug 1997 | A |
5690249 | Karlsten | Nov 1997 | A |
5833089 | Manni et al. | Nov 1998 | A |
5865796 | McCabe | Feb 1999 | A |
5899880 | Bellhouse et al. | May 1999 | A |
5947928 | Muller | Sep 1999 | A |
6003706 | Rosen | Dec 1999 | A |
6004286 | Bellhouse et al. | Dec 1999 | A |
6010478 | Bellhouse et al. | Jan 2000 | A |
6013050 | Bellhouse et al. | Jan 2000 | A |
6165155 | Jacobsen et al. | Dec 2000 | A |
6168587 | Bellhouse et al. | Jan 2001 | B1 |
6276547 | Petryna | Aug 2001 | B1 |
6475181 | Potter et al. | Nov 2002 | B1 |
6592545 | Bellhouse et al. | Jul 2003 | B1 |
6595352 | Bleuer | Jul 2003 | B2 |
6685669 | Bellhouse et al. | Feb 2004 | B2 |
6881200 | Bellhouse et al. | Apr 2005 | B2 |
6923800 | Chen et al. | Aug 2005 | B2 |
6929005 | Sullivan et al. | Aug 2005 | B2 |
6949154 | Hochrainer et al. | Sep 2005 | B2 |
6953039 | Scarrott et al. | Oct 2005 | B2 |
6966899 | Hochman et al. | Nov 2005 | B2 |
7014651 | Worthen et al. | Mar 2006 | B2 |
7044134 | Khairkhahan et al. | May 2006 | B2 |
7121402 | Van Heerden et al. | Oct 2006 | B2 |
7562771 | Fontana | Jul 2009 | B2 |
7614496 | Dvorak et al. | Nov 2009 | B2 |
7618394 | Bellhouse et al. | Nov 2009 | B2 |
7691407 | Clarke et al. | Apr 2010 | B2 |
7942846 | Bellhouse et al. | May 2011 | B2 |
20010015326 | Bleuer | Aug 2001 | A1 |
20020091353 | Bellhouse et al. | Jul 2002 | A1 |
20030019558 | Smith et al. | Jan 2003 | A1 |
20040158197 | Bellhouse et al. | Aug 2004 | A1 |
20050010168 | Kendall | Jan 2005 | A1 |
20060272963 | Sharon | Dec 2006 | A1 |
20060289316 | Henry | Dec 2006 | A1 |
20070185450 | De Polo et al. | Aug 2007 | A1 |
20090110723 | McAllister | Apr 2009 | A1 |
20100298767 | Bates et al. | Nov 2010 | A1 |
Number | Date | Country |
---|---|---|
1 047 385 | Dec 1958 | DE |
0 313 992 | May 1989 | EP |
0 371 838 | Jun 1990 | EP |
0 406 778 | Jan 1991 | EP |
0 458 641 | Nov 1991 | EP |
0 469 814 | Feb 1992 | EP |
0 734 737 | Oct 1996 | EP |
0 776 224 | Jun 1997 | EP |
0 951 917 | Oct 1999 | EP |
2 360 031 | Dec 1978 | FR |
501 564 | Mar 1939 | GB |
677 523 | Aug 1952 | GB |
2 206 794 | Jan 1989 | GB |
50-101521 | Aug 1975 | JP |
WO 9118991 | Dec 1991 | WO |
WO 9204439 | Mar 1992 | WO |
WO 9210225 | Jun 1992 | WO |
WO 9212799 | Aug 1992 | WO |
WO 9303779 | Mar 1993 | WO |
WO 9519799 | Jul 1995 | WO |
WO 9901168 | Jan 1999 | WO |
WO 9901169 | Jan 1999 | WO |
WO 0044421 | Aug 2000 | WO |
WO 0062846 | Oct 2000 | WO |
WO 0105455 | Jan 2001 | WO |
WO 0207803 | Jan 2002 | WO |
WO 02055139 | Jul 2002 | WO |
WO 2007141501 | Dec 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20040255447 A1 | Dec 2004 | US |
Number | Date | Country | |
---|---|---|---|
60307986 | Jul 2001 | US |